575 logo

Regent Pacific Group Limited Stock Price

SEHK:575 Community·HK$233.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

575 Share Price Performance

HK$0
-0.35 (-100.00%)
HK$0
-0.35 (-100.00%)
Price HK$0

575 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with weak fundamentals.

5 Risks
1 Reward

Regent Pacific Group Limited Key Details

US$833.0k

Revenue

US$795.0k

Cost of Revenue

US$38.0k

Gross Profit

US$4.1m

Other Expenses

-US$4.1m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.014
4.56%
-489.32%
-29.9%
View Full Analysis

About 575

Founded
1991
Employees
17
CEO
Jamie Alexander Gibson
WebsiteView website
www.regentpac.com

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services. The company was formerly known as Endurance RP Limited and changed its name to Regent Pacific Group Limited in July 2023. Regent Pacific Group Limited was founded in 1991 and is headquartered in Central, Hong Kong.

Recent 575 News & Updates

Recent updates

No updates